Science
COVID-19 data scandal prompts tweaks to elite journal’s review process – Science Magazine
After publishing study based on unverified patient data from Surgisphere, a little-known company, The Lancet promises tighter standards
By Kelly ServickSep. 18, 2020 , 2:40 PM
Sciences COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
Three months after retracting a high-profile COVID-19 paper, editors at The Lancet hope to assure the research community that theyve learned their lesson. The journal yanked a study on risks of hydroxychloroquinean antimalarial drug whose proposed use as a COVID-19 treatment has stirred scientific and political controversyin June when its authors couldnt pr…
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business19 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News15 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
General6 hours agoThe right-wing stupidity repeating Liberal Party history